🔗 Share this article Patients Discontinuing Weight-Loss Injections Regain Pounds Far More Rapidly Than Those on Conventional Diets Obesity treatment involves ongoing approaches. New research suggests that people who discontinue new slimming jabs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who halt traditional diet and exercise programs. Findings released in a leading health publication points out that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping. "Users using these drugs need to be cognizant of the risk of quick weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb. This pace of regain means a return to pre-treatment mass in about one and a half years. Weighing Therapies The research, which looked at 37 of studies involving over 9,000 of participants, compared the effects of these new drugs with other pills. The team point out that people who shed pounds through lifestyle changes alone typically see a less rapid weight regain—approximately 0.1 kg a month—once they finish. The Reason for the Quick Rebound Nutrition scientists suggest the mode of action of the injections explains the amplified weight return. The injections copy a body's own chemical called GLP-1, which helps regulate appetite. "Artificially providing the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist. "Stopping of this medication leads to appetite is uncontrolled, making binge eating much more probable." A Lifelong Disease? Medical guidelines advise the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes. A number of clinicians say that, considering the likelihood of relapse, the treatment should be considered ongoing. This perspective is echoed by drug manufacturers, who note that the findings "underscore the long-term nature of obesity," comparing it to managing diseases like diabetes. User Testimonies People who have discontinued the jabs explain a intense return of appetite. "I experienced a switch flipping and I was suddenly starving," described an individual. The struggle is exacerbated if patients have not developed lasting lifestyle or habit modifications during treatment. Widespread Adoption Figures show that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire being substantial. Use is higher among females than males. The 40s and 50s demographic shows the highest level of interest. A large proportion obtain the drugs through private prescriptions rather than public health services. Ultimately, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a standalone solution and long-term success likely depends on ongoing lifestyle support.
Obesity treatment involves ongoing approaches. New research suggests that people who discontinue new slimming jabs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who halt traditional diet and exercise programs. Findings released in a leading health publication points out that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping. "Users using these drugs need to be cognizant of the risk of quick weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb. This pace of regain means a return to pre-treatment mass in about one and a half years. Weighing Therapies The research, which looked at 37 of studies involving over 9,000 of participants, compared the effects of these new drugs with other pills. The team point out that people who shed pounds through lifestyle changes alone typically see a less rapid weight regain—approximately 0.1 kg a month—once they finish. The Reason for the Quick Rebound Nutrition scientists suggest the mode of action of the injections explains the amplified weight return. The injections copy a body's own chemical called GLP-1, which helps regulate appetite. "Artificially providing the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist. "Stopping of this medication leads to appetite is uncontrolled, making binge eating much more probable." A Lifelong Disease? Medical guidelines advise the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes. A number of clinicians say that, considering the likelihood of relapse, the treatment should be considered ongoing. This perspective is echoed by drug manufacturers, who note that the findings "underscore the long-term nature of obesity," comparing it to managing diseases like diabetes. User Testimonies People who have discontinued the jabs explain a intense return of appetite. "I experienced a switch flipping and I was suddenly starving," described an individual. The struggle is exacerbated if patients have not developed lasting lifestyle or habit modifications during treatment. Widespread Adoption Figures show that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire being substantial. Use is higher among females than males. The 40s and 50s demographic shows the highest level of interest. A large proportion obtain the drugs through private prescriptions rather than public health services. Ultimately, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a standalone solution and long-term success likely depends on ongoing lifestyle support.